Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis
Zhaoguo Liu, Pingting Zhu, Lin Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 103, pp. 1262-1271
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50
Celastrol exerts anti‐inflammatory effect in liver fibrosis via activation of AMPK‐SIRT3 signalling
Yuqin Wang, Minjing Li, Jingya Gu, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 941-953
Open Access | Times Cited: 82
Multiple Biological Effects of an Iridoid Glucoside, Catalpol, and Its Underlying Molecular Mechanisms
Subrat Kumar Bhattamisra, Kah Heng Yap, Vikram Rao, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 32-32
Open Access | Times Cited: 79
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Ralf Weiskirchen, Frank Tacke
Cells (2019) Vol. 8, Iss. 1, pp. 16-16
Open Access | Times Cited: 77
Monoterpenes modulating autophagy: A review study
Milad Ashrafizadeh, Zahra Ahmadi, Reza Mohammadinejad, et al.
Basic & Clinical Pharmacology & Toxicology (2019) Vol. 126, Iss. 1, pp. 9-20
Open Access | Times Cited: 65
Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety
Ying Bai, Ruyuan Zhu, Yimiao Tian, et al.
Molecules (2019) Vol. 24, Iss. 18, pp. 3302-3302
Open Access | Times Cited: 65
Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases
Yajing Li, Runping Liu, Jianzhi Wu, et al.
Theranostics (2020) Vol. 10, Iss. 18, pp. 7993-8017
Open Access | Times Cited: 50
Catalpol Attenuates Oxidative Stress and Inflammation via Mechanisms Involving Sirtuin-1 Activation and NF-κB Inhibition in Experimentally-Induced Chronic Kidney Disease
Nur Elena Zaaba, Suhail Al‐Salam, Sumaya Beegam, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 237-237
Open Access | Times Cited: 17
Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
Yan Chen, Qingpu Liu, Zengfu Shan, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 54
Study on the inhibitive effect of Catalpol on diabetic nephropathy
Jing Chen, Yuwei Yang, Zhiyang Lv, et al.
Life Sciences (2020) Vol. 257, pp. 118120-118120
Closed Access | Times Cited: 49
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways
Aimin Liu, Buxin Zhang, Wei Zhao, et al.
Bioengineered (2020) Vol. 12, Iss. 1, pp. 183-195
Open Access | Times Cited: 47
Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice
Huihui Ren, Dan Wang, Lu Zhang, et al.
Aging (2019) Vol. 11, Iss. 21, pp. 9461-9477
Open Access | Times Cited: 45
Catalpol‑mediated microRNA‑34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer
Pengfei Qiao, Lei Yao, Zhaolin Zeng
Oncology Reports (2020)
Open Access | Times Cited: 42
Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway
Juanjuan Li, He-Chun Jiang, Ao Wang, et al.
European Journal of Pharmacology (2021) Vol. 915, pp. 174530-174530
Closed Access | Times Cited: 33
Hepatoprotective and neuroprotective effect of taxifolin on hepatic encephalopathy in rats
Ufuk Okkay, Irmak Ferah Okkay, Betül Çiçek, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 5, pp. 1541-1556
Closed Access | Times Cited: 26
Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease
Yan Wang, Zhun Sui, Mi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Exploration of the Dynamic Variations of the Characteristic Constituents and the Degradation Products of Catalpol during the Process of Radix Rehmanniae
Jingjing Yang, Lihua Zhang, Meng-Yue Zhang, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 705-705
Open Access | Times Cited: 5
Co-catalpol alleviates fluoxetine-induced main toxicity: Involvement of ATF3/FSP1 signaling-mediated inhibition of ferroptosis
Xiaohui Wu, Yuechen Guan, Junming Wang, et al.
Phytomedicine (2024) Vol. 126, pp. 155340-155340
Closed Access | Times Cited: 5
Inhibiting autophagy promotes collagen degradation by regulating matrix metalloproteinases in pancreatic stellate cells
Caixia Li, Lihua Cui, Yuzhen Zhuo, et al.
Life Sciences (2018) Vol. 208, pp. 276-283
Closed Access | Times Cited: 45
Catalpol induces apoptosis in breast cancer in vitro and in vivo: Involvement of mitochondria apoptosis pathway and post-translational modifications
Jierong Liu, Jikun Du, Yuanhua Li, et al.
Toxicology and Applied Pharmacology (2022) Vol. 454, pp. 116215-116215
Closed Access | Times Cited: 19
Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
Yan Xue, Wanchun Zhu, Fengjie Qiao, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118169-118169
Open Access | Times Cited: 4
Multifaceted therapeutic potentials of catalpol, an iridoid glycoside: an updated comprehensive review
Mennat-Allah M. Hassan, Mohamed I. Fahmy, Hany N. Azzam, et al.
Inflammopharmacology (2025)
Open Access
CCN5-Derived Peptide Ameliorates Liver Fibrosis in Mice through Inhibiting the ERK1/2 and PI3K Signaling Pathways
R. Fang, Chuangnan Qiu, Can Xiao, et al.
ACS Omega (2025)
Open Access
Iridoid Glycosides in Kidney-Tonifying Chinese medicinal herbs: Mechanisms and Implications for Alzheimer’s Disease Therapy
Yanjie Qu, Min-Rui Ding, Mengxue Zhang, et al.
Journal of Ethnopharmacology (2025) Vol. 348, pp. 119870-119870
Closed Access
Gallic acid protects against ethanol-induced hepatocyte necroptosis via an NRF2-dependent mechanism
Ying Zhou, Huanhuan Jin, Yu Wu, et al.
Toxicology in Vitro (2019) Vol. 57, pp. 226-232
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top